VALENCIA, Calif.--(BUSINESS WIRE)--Bioness, Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared the StimRouter®, an implantable neuromodulation device designed to treat chronic ...
Another startup from controversial med tech visionary Alfred Mann is making its way to the fore: Bioness. He founded the company in 2004. Now, Bioness has gained clearance from the FDA for its ...
DURHAM – Global medical technology company Bioventus, which went public earlier this year, is growing bigger with an acquisition. The company announced Tuesday it had acquired California-based Bioness ...
ODESSA - For many people, walking around your home from one room to another is something you don't even think twice about. For others, taking a few steps is hard and even dangerous at times. Medical ...
Bioventus Inc. has acquired medical devices provider Bioness Inc. for a total consideration of $110 million. This includes an up-front payment of $45 million and milestone payments of up to $65 ...
Bioness was established in 2004 to help individuals with neurological impairments regain their independence, according to the company website. With the support of entrepreneur and philanthropist ...
Bioness’ Ness L300 Plus unit. As Alfred Mann struggles to get the first product from his public drug developer MannKind Inc. approved, one of his smaller companies has received the Food and Drug ...
VALENCIA, Calif.--(BUSINESS WIRE)--Bioness Inc. today announced that its Board of Directors has named Todd Cushman as the company’s President and CEO in an effort to refine its strategy and reorganize ...
DUBLIN, June 21, 2021 /PRNewswire/ -- The "Neurorehabilitation Devices - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Amid the COVID-19 crisis, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback